NDC49281-0126-65: INFLUENZA VIRUS VACCINE.
The INFLUENZA VIRUS VACCINE is a the manufacturer industrial component. Key specifications include protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, part_name_assigned_by_controlling_agency: INFLUENZA VIRUS VACCINE, USP, FLUZONE HIGH DOSE; 2026-2027 FORMULA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-735-0237, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| part_name_assigned_by_controlling_agency | INFLUENZA VIRUS VACCINE, USP, FLUZONE HIGH DOSE; 2026-2027 FORMULA |
| NSN | 6505-01-735-0237 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| SPECIAL FEATURES | TRIVALENT PREFILLED SYRINGE; 0.5 ML SINGLE DOSE PREFILLED SYRINGE, PG OF 10 (W/O NEEDLES); INACTIVATED INFLUENZA VACCINE; FOR FLU SEASON 2026-2027; FOR IMMUNIZING PERSONS 65 YEARS OF AGE AND OLDER; LATEX-FREE, PRESERVATIVE FREE; FOR IM ADMINISTRATION; REQUIRES REFRIGERATION BETWEEN 2-8 DEG C; DO NOT FREEEZE DEGC |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | INFLUENZA VIRUS VACCINE, USP, FLUZONE HIGH DOSE; 2026-2027 FORMULA |